RadNet Bolsters AI Arsenal with €230M Acquisition of French Radiology Specialist Gleamer
This analysis is based on a report originally published by MedTech Dive. For daily updates on the medical technology sector, subscribe to the free MedTech Dive newsletter.
In a strategic push to consolidate its leadership in artificial intelligence-driven diagnostics, RadNet, one of the largest U.S. providers of outpatient imaging services, has announced the acquisition of French radiology AI firm Gleamer for an initial €215 million, with an additional €15 million contingent on performance milestones. The deal, finalized this week, signals intensifying competition to embed AI directly into the core workflow of radiology departments worldwide.
Gleamer brings to the table a clinically validated portfolio, including its flagship BoneView software for fracture detection in X-rays, alongside AI tools for identifying lung nodules on CT scans and multiple sclerosis lesions on brain MRIs. The company holds FDA clearances for four devices and CE marks for six products, providing RadNet with immediate regulatory pathways in both the U.S. and European markets.
"This acquisition is about completeness and connectivity," RadNet CEO Howard Berger explained during an investor call. "Gleamer allows us to round out our routine imaging portfolio with proven AI tools. More importantly, it enables a unified platform where every point of care—from emergency rooms to physician groups—can be connected, streamlining the entire diagnostic journey."
Berger directly addressed the competitive landscape, contrasting RadNet's approach with GE HealthCare's recent $2.3 billion purchase of Intelerad. He argued that while Intelerad focuses on a segment of IT infrastructure, RadNet's growing AI suite, now bolstered by Gleamer, aims to impact the full radiology department workflow, whether hospital-based or outpatient.
The transaction is also a key part of RadNet's international strategy. Sham Sokka, RadNet's Chief Operating and Technology Officer for Digital Health, noted that Gleamer's established presence in Europe will serve as a springboard for broader global commercialization of their combined AI and workflow capabilities.
Financially, RadNet anticipates approximately $7 million in cost synergies from the integration. The company, which recently reported strong annual results, forecasts its digital health division sales to surge 45% to 55% this year, with Gleamer expected to be a significant contributor to that growth, according to CFO Mark Stolper.
This acquisition marks RadNet's latest step in a multi-year AI build-up, following its 2020 purchase of DeepHealth and last year's additions of iCAD, See-Mode, and CIMAR to its digital health portfolio.
Expert & Industry Reaction:
"This is a logical and powerful consolidation," says Dr. Anya Sharma, a radiologist at Metropolitan General Hospital. "Having fracture detection, lung nodule analysis, and neurology tools from a single integrated platform could drastically reduce the time we spend switching between disparate systems. If it delivers on the promise of a seamless workflow, it's a win for patient throughput."
"The price tag raises eyebrows," comments Leo Crawford, a healthcare tech analyst at Finley Partners. "€230M for a company Gleamer's size is aggressive. RadNet is clearly paying a premium for European market access and a consolidated product suite. The pressure is now on to demonstrate those 'cost synergies' and achieve the projected sales growth to justify the investment."
"Here we go again—another promising independent AI innovator swallowed by a giant," offers a more critical Maya Chen, founder of a small AI diagnostics startup. "Consolidation might streamline things for big providers like RadNet, but it stifles niche innovation and reduces choice for hospitals. It also centralizes immense power over diagnostic pathways into very few hands. Is that really good for medicine in the long term?"
"The GE comparison is telling," observes Professor David Finch, a healthcare policy expert. "We're witnessing a land grab in radiology AI infrastructure. The goal is no longer just selling software; it's about becoming the indispensable operating system for the entire imaging department. RadNet's latest move positions it as a formidable, full-stack contender in that race."
Recommended Reading